NATPARA

Because of the potential risk of osteosarcoma, NATPARA is only recommended for patients who cannot be well-controlled on calcium and active forms of vitamin D alone and for whom the potential benefits are considered to outweigh this potential risk... Find the NATPARA Risk Evaluation and Mitigation Strategy here, with information on prescriber certification and pharmacy certification.

Primary location: Lexington United States